Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Butler, Kyle V., Kalin, Jay, Brochier, Camille, Vistoli, Guilio, Langley, Brett, Kozikowski, Alan P.·2010·Journal of the American Chemical Society
DOI 10.1021/ja102758v

Cited by (902)

Items 701–800 of 902

  1. In Vitro Histone Deacetylase Activity Screening
    Quaovi H. Sodji, James R. Kornacki, Milan Mrksich, Adegboyega K. Oyelere · 2015 · Elsevier eBooks
  2. Targeting Selective Autophagy of Insoluble Protein Aggregates
    Pierfausto Seneci · 2015 · Elsevier eBooks
  3. Screening of a Histone Methyltransferase Inhibitor in Animal Models of Psychiatric Illness
    Joel Kosowan · 2014 · TSpace (University of Toronto)
  4. The Role of HDAC6 and HDAC11 in Shaping Anti-Tumor Responses – Insights into Epigenetic Regulation of Tumor and T-Cell Immunobiology
    Karrune V. Woan · 2012 · University of Florida Digital Collections (University of Florida)
  5. Can histone epigenetic profiling become an alternative treatment modality for colon cancer?
    Thulasi G Pillai · 2018 · MOJ Proteomics & Bioinformatics
  6. Computer‐based Lead Identification for Epigenetic Targets
    Chiara Luise, Tino Heimburg, Berin Karaman, Dina Robaa, Wolfgang Sippl · 2019 · Methods and principles in medicinal chemistry
  7. Chemical hypoxia in human pluripotent NT2 stem cell-derived neurons: Effect of hydroxamic acid and benzamide-based epigenetic drugs
    Rushita Adhikari Bagchi, Ashim Kumar Bagchi, Ankita Salunke, Dipak K Hens, Pragna Parikh · 2019 · Neuroscience Research Notes
  8. Structure-Based Design of Epigenetic Inhibitors
    Dina Robaa, Jelena Melesina, Chiara Luise, Wolfgang Sippl · 2019 · Topics in medicinal chemistry
  9. Modulation of neuronal mitochondrial dynamics, autophagy and huntingtin proteostasis by HDAC inhibitors: Insights for Huntington's disease
    Pedro Gonçalo Guedes Dias · 2015 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  10. Progress in the Research of Selective Histone deacetylase Inhibitors
    立园 张 · 2021 · Advances in Material Chemistry
  11. Restoring vascular endothelial autophagic flux reduces atherosclerotic lesions
    Shruti Chatterjee, Marouane Kheloufi, Stephane M. Ibraham Mazlan, Xavier Loyer, Timothy A. McKinsey, Chantal M. Boulanger, Pierre‐Michaël Coly · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  12. Targeting (de)acetylation: A Diversity of Mechanism and Disease
    Colleen E. Quaas, David T. Long · 2021 · Elsevier eBooks
  13. Inhibition of histone deacetylase 6 by tubastatin A as an experimental therapeutic strategy against glioblastoma
    Alejandro Urdiciain, Paola Bermudez‐Lekerika, Bárbara Meléndez, JUAN ANTONIO REY, Miguel Angel Idoate, Natalia A. Riobo‐Del Galdo, Javier S. Castresana · 2021 · Glioma
  14. [Investigation of operative process in treating lumbar intervertebral disc protrusion in aged patients].
    Long-Jun Zhang, Xiao-Dong Zheng, Jianliang Chen, Ying-Gang Shao, Jing Chen · 2013 · PubMed
  15. Faculty Opinions recommendation of Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition.
    Mark A. Bothwell · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  16. Authors Profile
    Alan P. Kozikowski · 2010 · ChemMedChem
  17. Desenvolvimento de inibidores duais de histona desacetilase 6 (HDAC6) e tirosina quinase (TQ) com vistas ao tratamento do câncer
    Maurício T. Tavares · 2019
  18. Papel da HDAC6 na regulação do estresse oxidativo e quimiorresistência de células-tronco tumorais em carcinoma oral
    Marcela Oliveira Tavares · 2022
  19. Supplementary References from Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies
    Hee-Sheung Lee, Nathan Lee, Natalay Kouprina, Jung-Hyun Kim, Alex Kagansky, Susan Elaine Bates, Jane B. Trepel, Yves G. Pommier, Dan L. Sackett, Vladimir Larionov · 2023
  20. Peer Review #3 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.1)"
    2023 · PeerJ
  21. Peer Review #2 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.2)"
    2023 · PeerJ
  22. Peer Review #2 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.1)"
    2023 · PeerJ
  23. Peer Review #1 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.2)"
    2023 · PeerJ
  24. Peer Review #1 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.1)"
    2023 · PeerJ
  25. Peer Review #3 of "Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis (v0.2)"
    2023 · PeerJ
  26. Contilisant+Tubastatin A hybrids, as new multi-target-directed polyfunctionalized indole derivatives able to inhibit histone deacetylase/cholinesterase/monoamine oxidase enzymes, and modulate histamine 3/sigma 1/5-HT6/dopamine 3 receptors for the treatment of cancer
    Jose Luis Marco, Mireia Toledano‐Pinedo, Fernando Romero, Abdelouahid Samadi, Alicia Porro, Pedro Almendros, Isabel Iriepa, M. Mercedes Rodríguez‐Fernández, Francisco Javier Lopez-Munoz, Aizpea Artetxe-Zurutuza et al. · 2023 · ChemRxiv
  27. Design and Synthesis of Novel 3- Arylil 2-oxindole for Sirtuin 2 Inhibition
    Mehdi Sheikh Arabi, Pouyan Asadi, Safoura Khajeniazi · 2022 · Research Square
  28. TỔNG QUAN VỀ HDAC6 VÀ CÁC CHẤT ỨC CHẾ CHỌN LỌC HDAC6 HƯỚNG TÁC DỤNG KHÁNG UNG THƯ
    Tiến Anh Dương · 2023 · Tạp chí Nghiên cứu Khoa học và Phát triển
  29. Virtual screening for early identification of potent and selective histone deacetylase 6 inhibitor series
    Shawn J. Stachel, Deping Wang, Anthony T. Ginnetti, Shahriar Niroomand, Lei Ma, YingHui Hu, John F. Fay, Wei Lemaire, Daniel J. Krosky, Andres D. Ramirez et al. · 2023 · Bioorganic & Medicinal Chemistry Letters
  30. Histone Deacetylase Inhibitors: Design, Synthesis, and Biological Evaluation
    Sravani Pulya, Abhiram Ganorkar, Swati Biswas, Balaram Ghosh · 2023 · Springer eBooks
  31. The Progress of Research in Molecular Structure and Function of Histone Deacetylase 6
    Xiaoyan Zhu, Wenke Zhou · 2023 · International Journal of Biology and Life Sciences
  32. Blocking microtubule deacetylation inhibits anaphase chromosome movements in crane-fly spermatocytes
    Maral Janan, Jess MacPherson, Arthur Forer · 2024 · PLoS ONE
  33. Structure similarity based screening coupled to integrated structural biochemistry approach for exploring the high affinity inhibitors against histone deacetylase (HDAC)-6
    Shabir Ahmad Ganai, Suma Mohan S · 2025 · In Silico Pharmacology
  34. Modulation of the cell cycle and inhibition of histone deacetylases by small molecules increase recombinant adeno‐associated virus productivity across different HEK293 cell lines
    Nikola Krämer, Kathrin E. Teschner, Alyssa Buve, Luisa Scheller, Pia Brinkert, Vera Ortseifen, Sandra Klausing · 2025 · Biotechnology Progress
  35. Use of histone deacetylase inhibitors (HDACis) in pancreatic ductal adenocarcinoma (PDAC): A narrative review
    Vassiliki Tarara, Evangelos Karamitrousis · 2025 · Forum of Clinical Oncology
  36. Discovery of Pyrazolo[1, 5‐a]pyrimidine‐Based Selective HDAC6 Inhibitors with Broad‐Spectrum Antiproliferative Activity
    Wendeng Li, Chunhong Ma, Changchun Ye, Xiaoya Chen, Shiyuan Liu, Zilu Chen, Xin Chen, Zhengshui Xu · 2025 · ChemMedChem
  37. Thermal shift engagement assay for Class IIA histone deacetylase inhibitor screening
    Lauren N. Kotsull, Mary Kay H. Pflum · 2025 · Results in Chemistry
  38. Monothiooxalamide–Benzothiazole Hybrids: Predictive Docking on HDAC6, Synthesis, Molecular Structure, and Antiproliferative Activity on Breast Cancer Cells
    Carlos Eduardo Macías-Hernández, Irving Balbuena-Rebolledo, Efrén V. Garcı́a-Báez, Laura Cristina Cabrera Pérez, Marycarmen Godínez‐Victoria, Martha Cecilia Rosales‐Hernández, Itzia Irene Padilla Martínez · 2025 · International Journal of Molecular Sciences
  39. Zinc-Dependent Histone Deacetylase (HDAC) Inhibitors: Therapeutic Potential, Pharmacophore Structure, and Methods for Testing Deacylase Activity
    Anastasia S. Zemskaya, Sergey N. Kochetkov, Maxim V. Kozlov · 2025 · Molecular Biology
  40. Green C3-Aminomethylation of Indoles
    Qiu-Qi Mu, Changjiang Li, Juan Wang, Li Xu, Sai-Fei Xia, Yan Wang, Bingbing Han, Xing-Le Liu, Li‐Wen Xu · 2025 · The Journal of Organic Chemistry
  41. HDAC11 Deacetylates BRAF to Regulate Kinase Activity and Cell Proliferation
    Chidi Augustine Madueke, Rafael Enrique Andrade, Mary Kay H. Pflum · 2025 · ACS Chemical Biology
  42. Additional file 2 of Abolished clustering of MeCP2T158M can be partially reverted with small molecules
    Rodrigo Lata, Liesbeth Steegmans, Ranie Kellens, Nijs, Marnik, Hugo Klaassen, Matthias Versele, Frauke Christ, Zeger Debyser · 2024 · Figshare
  43. Additional file 1 of Abolished clustering of MeCP2T158M can be partially reverted with small molecules
    Rodrigo Lata, Liesbeth Steegmans, Ranie Kellens, Nijs, Marnik, Hugo Klaassen, Matthias Versele, Frauke Christ, Zeger Debyser · 2024 · Figshare
  44. Inhibition of HDAC6 promotes in vitro maturation of Tan sheep oocytes by bidirectionally and synergistically regulating EGFR/CNP expression via histone acetylation
    Yujie Yan, Donghuan Lv, Zhipeng Qi, Xiangyan Wang, Jinghua Wang, Hongyuan Song, Junli He, Sirui Min, Qiang Chen, Xinfeng Liu · 2025 · Theriogenology
  45. Intravitreal Administration of a Selective HDAC6 Inhibitor Prevents Retinal Damage Progression in the Acute Ocular Toxoplasmosis Model
    Carlla Assis Araújo-Silva, Milena Ribeiro Peclat-Araujo, Vanderlei da Silva Fraga‐Junior, Thuany Prado Rangel, Dio Pablo Alexandrino-Mattos, Claudia Farias Benjamim, Christina Maeda Takiya, Wanderley de Souza, Rossiane Cláudia Vommaro · 2026 · ACS Infectious Diseases
  46. HDAC6 exacerbates osteoarthritis by promoting macrophage inflammation-mediated chondrocyte degeneration
    Shimin Wang, Liping Fu, Wenquan Qiu, Junyu Ouyang, Delong Song, Zilong Song, Yexuan Zhu, Zheng Yan, Fujun Jin, Yu-Jing Lu et al. · 2026 · International Immunopharmacology
  47. Discovery of tetrahydroisoquinoline derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities
    Shiru Liu, Baiyun Dang, Zhiwen Kang, Ru Wei, Zhanyuan Yang, Xiangxin Guo, Feixiang Shao, Zhen Li, Liang Xing, Jiadong Hu et al. · 2026 · Bioorganic & Medicinal Chemistry Letters
  48. Synthesis of N -Ester Carbazoles Using Diethyl Azodicarboxylate as Carbon Source
    Liangxin Fan, Mengyao Shi, Xingyuan Liu, Zhenliang Pan, Guoyu Yang, Lulu Wu, Xiaoping Xue, Li Dai, Cuilian Xu · 2026 · Chinese Journal of Organic Chemistry
  49. EPIADDICT - Synthèses de nouveaux inhibiteurs des histones désacétylases et leur intérêt dans un modèle préclinique d’addiction à l’alcool.
    Mathieu Létévé · 2016 · theses.fr (ABES)
  50. Combinaisons de nouveaux inhibiteurs de désacétylase d’histones 6 avec des inhibiteurs de tyrosine kinase pour le traitement de la leucémie myéloïde chronique
    Hélène Losson · 2020
  51. Restoration of autophagic flux in vascular endothelial cells to prevent atherosclerosis lesion development
    Shruti Chatterjee · 2020
  52. Biochemical, biophysical and structural study of proteins associated to human diseases : tcDAC2 and ADAT complex
    Elizabeth Ramos‐Morales · 2021 · theses.fr (ABES)
  53. An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020–2025)
    Sida Shen · 2026 · Expert Opinion on Therapeutic Patents
  54. Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria
    Wisam A. Dawood, Jacinta R. Macdonald, Christian Anzenhofer, Tina S. Skinner‐Adams, Robert C. Reid, Thomas Kurz, David P. Fairlie, Katherine T. Andrews · 2026 · Medicinal Research Reviews
  55. Macrophage-Centric Phenotypic Screening Identifies Tetrazolone-Based HDAC6 Inhibitors That Reprogram the Tumor Immune Microenvironment and Improve Immune Checkpoint Blockade
    Nithya Gajendran, Manasa Suresh, Sebastian Marquez R., Sruthi Mohan, Tim Ponsot, David Quiceno-Torres, Mario A. Noboa, Bryan T. Weselman, Xintang Li, Marie Durr et al. · 2026 · Journal of Medicinal Chemistry
  56. Targeting HDAC6 and its novel E3 ligase activity: A dual-strategy for cardiovascular therapy
    Xingjuan Shi, Ziyang Zhao, Weiying Yue, Shiyi Feng, Nan Zhang, Xiaoou Sun · 2026 · Ageing Research Reviews
  57. Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer Treatment
    W CHEN, Xiaoling Cheng, Xi Zhao, Z Chen, Yupei Lai, Wenli Hao, ZhenDan He, Wenhong Lin, Yan Wu, Yaping Guo et al. · 2026 · Journal of Medicinal Chemistry
  58. CaMKII–LUZP1 signaling couples cytoskeletal acetylation and autophagy to drive neuronal plasticity
    Chao‐Yuan Tsai, Kazuki Kuroda, Yuichiro Oka, Manabu Taniguchi, Hideshi Yagi, Makoto Sato · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Purine and Pyrrolopyrimidine‐Based Small Molecules as Multitarget Therapeutics
    Federica Borghi, Antonio Laus, Claudia Sorbi, Giulio Rastelli · 2026 · Archiv der Pharmazie
  60. HDAC6 is a biomarker of leukaemic dissemination and relapse in B-ALL
    Karina E. Jiménez-Camacho, Hilda Vargas‐Robles, Joseph Adomako, Ana Beatriz Sánchez-Argáez, Correa Lara Maximiliano, Antonio Sandoval-Cabrera, Elisa María Dorantes-Acosta, Juan Manuel Mejía‐Aranguré, Sara Castañeda-Contreras, Juan Carlos Núñez-Enríquez et al. · 2026 · British Journal of Cancer
  61. Metalloprotein-Targeted Inhibitors: A Promising Strategy for Novel Pesticide Discovery
    Huimin Chen, Fang Qin, Dong Shu-yu, Yuting Xiang, Wishwajith Kandegama, Xing-Xing Shi, Ge‐Fei Hao, Guang‐Fu Yang · 2026 · Journal of Agricultural and Food Chemistry
  62. Chemical probes for Alzheimer’s disease targets
    Sheenagh Aiken, Tryfon Zarganes‐Tzitzikas, Paul E. Brennan · 2026 · Essays in Biochemistry
  63. Design, synthesis, and biological evaluation of selective HDAC6 inhibitors featuring an N-benzyl-2-(aryl/heteroaryl)acetamide cap
    Tingting Li, Lingfang Wei, He Shi, Wenying Yan, Yujie Sun, Y. F. Zhang, Yiteng Wang, Xiangyu Lu, Yan Fu, Zhaobo Liu et al. · 2026 · Bioorganic Chemistry
  64. Synthesis of β ‐ and γ ‐Carbolinones Through a Fe(III)‐Mediated Radical 6‐ Endo ‐Trig Cyclization of Indole‐Based Ugi 4‐CR Adducts
    María F. Olvera‐Granados, Luis A. Polindara‐García · 2026 · European Journal of Organic Chemistry
  65. The Primary Cilium: A New Player in Muscle Stem Cell Biology
    Anna Rausch de Traubenberg, Ludivine Rotard, Caroline E. Brun · 2026 · Stem Cell Reviews and Reports
  66. Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease
    Jianan Ye, Sijia Yin, Yutao Lin, Shuhui Yang, Lieen Ma, Yang Wang, Kangyang Gao, Yule Wang, Xinhang Yang, Zhichao Yang et al. · 2026 · European Journal of Medicinal Chemistry
  67. Discovery of first histone deacetylase 10 fluorescent probe
    Ching Lin, Yueh‐Feng Wu, Sian-Siou Wu, Yu-Ying Lin, Ching-Ju Cheng, Ajit Dhananjay Jagtap, Miao‐Hsia Lin, Chao‐Wu Yu · 2026 · Bioorganic Chemistry
  68. Crosstalk between ubiquitination and other post-translational modifications in cardiovascular diseases
    Yi Yan, Zhiqiang Li, Tingting Xiao · 2026 · iScience
  69. Structure-Based Design of HDAC6 Inhibitors Targeting the L2 Pocket: Modulating Autophagy and Liquid−Liquid Phase Separation in Lung Cancer
    Simona Barone, Abraham Eafa, Ivana Bello, Gessica Filocamo, Alessia Alberico, Emilia Cassese, Anna Guadagni, Heiko Rebmann, Emanuela G. Cosentino, Juana Goulart Stollmaier et al. · 2026 · Journal of Medicinal Chemistry
  70. Histone deacetylase 6 (HDAC6)-mediated α-tubulin (K40) deacetylation and microtubule destabilization disrupt autophagosome–lysosome fusion in PBDE-47-induced neurotoxicity
    Huayang Tang, Haoqi Hou, Zhiyuan Tian, Wenhui Liu, Gaoshuai Chen, Dongjie Li, Chenxi Wang, Ruijie Liu, Dan Wang, Tao Xia et al. · 2026 · Archives of Toxicology
  71. BindingDB Entry 50018882: Inside HDACs with more selective HDAC inhibitors.
    BindingDB · 2024 · UC San Diego
  72. BindingDB Entry 50048980: Ring-opened tetrahydro-¿-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms.
    BindingDB · 2019 · UC San Diego
  73. BindingDB Entry 50008290: Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.
    BindingDB · 2021 · UC San Diego
  74. BindingDB Entry 50040711: Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth.
    BindingDB · 2013 · UC San Diego
  75. BindingDB Entry 50021326: Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.
    BindingDB · 2025 · UC San Diego
  76. BindingDB Entry 50009719: A novel class of anthraquinone-based HDAC6 inhibitors.
    BindingDB · 2021 · UC San Diego
  77. BindingDB Entry 50008716: Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
    BindingDB · 2021 · UC San Diego
  78. BindingDB Entry 50048253: Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines.
    BindingDB · 2018 · UC San Diego
  79. BindingDB Entry 50011516: Recent advances in the discovery of potent and selective HDAC6 inhibitors.
    BindingDB · 2022 · UC San Diego
  80. BindingDB Entry 50018402: A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective.
    BindingDB · 2024 · UC San Diego
  81. BindingDB Entry 50019891: Discovery of the First Irreversible HDAC6 Isoform Selective Inhibitor with Potent Anti-Multiple Myeloma Activity.
    BindingDB · 2024 · UC San Diego
  82. BindingDB Entry 50047103: Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors.
    BindingDB · 2017 · UC San Diego
  83. BindingDB Entry 50042694: Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.
    BindingDB · 2013 · UC San Diego
  84. BindingDB Entry 50023609: Challenging triple negative breast cancer through HDAC6 selective inhibition: Novel cap-group identification, structure-activity relationships, computational and biological studies.
    BindingDB · 2026 · UC San Diego
  85. BindingDB Entry 50000363: (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo.
    BindingDB · 2019 · UC San Diego
  86. BindingDB Entry 50049324: Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
    BindingDB · 2019 · UC San Diego
  87. BindingDB Entry 50010135: Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease.
    BindingDB · 2021 · UC San Diego
  88. BindingDB Entry 50006699: Design, Synthesis, and Biological Evaluation of 2,4-Imidazolinedione Derivatives as HDAC6 Isoform-Selective Inhibitors.
    BindingDB · 2021 · UC San Diego
  89. BindingDB Entry 50033510: Computer- and structure-based lead design for epigenetic targets.
    BindingDB · 2012 · UC San Diego
  90. BindingDB Entry 50008782: Exploring hydroxamic acid inhibitors of HDAC1 and HDAC2 using small molecule tools and molecular or homology modelling.
    BindingDB · 2021 · UC San Diego
  91. BindingDB Entry 50013991: Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse Model.
    BindingDB · 2022 · UC San Diego
  92. BindingDB Entry 50007224: Molecular Basis for the Selective Inhibition of Histone Deacetylase 6 by a Mercaptoacetamide Inhibitor.
    BindingDB · 2021 · UC San Diego
  93. BindingDB Entry 50006278: Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors.
    BindingDB · 2020 · UC San Diego
  94. BindingDB Entry 50018506: β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy.
    BindingDB · 2024 · UC San Diego
  95. BindingDB Entry 50046606: Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators.
    BindingDB · 2016 · UC San Diego
  96. BindingDB Entry 50000428: Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat.
    BindingDB · 2019 · UC San Diego
  97. BindingDB Entry 50044723: Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors.
    BindingDB · 2016 · UC San Diego
  98. BindingDB Entry 50018910: Recent developments on synthesis and biological activities of γ-carboline.
    BindingDB · 2024 · UC San Diego
  99. BindingDB Entry 50022035: Discovery of novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo.
    BindingDB · 2025 · UC San Diego
  100. BindingDB Entry 50049149: Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors.
    BindingDB · 2019 · UC San Diego